About Edgewise Therapeutics Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://edgewisetx.com/
Frequently Asked Questions
What is the 52-week range for EWTX?
The 52-week high is $48.51 and the 52-week low is $14.25.
What is the P/E ratio for EWTX?
The P/E ratio data is currently unavailable.
What is the dividend yield for EWTX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -39.01%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.03.
Analyst Recommendation Trends
Wall Street analyst consensus for EWTX over the last few months:
Latest EWTX News
Edgewise Therapeutics (EWTX) Sets EDG 7500 Focus Call, Is It Still 20% Below Fair Value?
Edgewise Therapeutics (EWTX) drew fresh attention after scheduling a special call on September 22, 2026, to walk through the differentiated mechanism of action for its cardiac sarcomere modulator EDG-7500. The special EDG-7500 call lands after a powerful run for Edgewise Therapeutics, with a year to date share price return of 74.32% and a 1 year total shareholder return of 164.54%. However, the 30 day share price return declined 1.38%, suggesting that strong long term momentum may be pausing...
Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?
Bristol Myers' Camzyos gains a broader FDA label and strong sales growth, while emerging competitors and pipeline setbacks shape its cardiovascular outlook.
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today announced that on September 30, 2026, Edgewise granted inducement stock options to purchase a total of 7,500 shares of Edgewise's common stock and awards of inducement restricted stock units (each, an "RSU award") covering a total of 3,751 shares of Edgewise's common stock to 3 new non-executive employees in connection with the co
Edgewise Therapeutics Could Benefit From Differentiated EDG-7500 Profile, Oppenheimer Says
Edgewise Therapeutics (EWTX) could benefit from EDG-7500's differentiated drug profile, a potentiall
Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 Transcript
Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 September 22, 2026 8:30 AM...
Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 - Slideshow
2026-09-22. The following slide deck was published by Edgewise Therapeutics, Inc.
Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today announced that it will host an investor conference call to discuss the preclinical pharmacologic profile of EDG-7500, a first-in-class cardiac sarcomere modulator targeting the RLC. Data will be provided supporting EDG-7500's ability to improve cardiac relaxation while preserving overall systolic performance. Furthermore, early clinical observations in patients
HC Wainwright & Co. Maintains Buy on Edgewise Therapeutics, Raises Price Target to $57
HC Wainwright & Co. analyst Lander Egaña Gorroño maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Buy and raises the price target from $45 to $57.
Biotech Options Buzz: UTHR, NMRA, EWTX
UTHR, NMRA, and EWTX are drawing attention from options bears
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-13 | Donovan Joanne M. | -2,919 | $43.4065 | $126,704 |
| 2026-08-12 | Russell Alan J | +65,000 | - | - |
| 2026-08-12 | Derakhshan Behrad | +100,000 | - | - |
| 2026-08-12 | Nofi Michael | +48,750 | - | - |
| 2026-08-12 | Donovan Joanne M. | +65,000 | - | - |
| 2026-08-12 | MOORE JOHN R | +65,000 | - | - |
| 2026-08-12 | Russell Alan J | +65,000 | - | - |
| 2026-08-12 | Russell Alan J | +32,500 | - | - |
| 2026-08-12 | Russell Alan J | -7,031 | - | - |
| 2026-08-12 | Russell Alan J | -5,781 | - | - |
| 2026-08-12 | Russell Alan J | -390 | $44.46 | $17,339 |
| 2026-08-12 | Russell Alan J | -2,273 | $43.6759 | $99,275 |
| 2026-08-12 | Russell Alan J | -3,238 | $43.6775 | $141,428 |
| 2026-08-12 | Russell Alan J | +7,031 | - | - |
| 2026-08-12 | Russell Alan J | +5,781 | - | - |
| 2026-08-12 | Derakhshan Behrad | +100,000 | - | - |
| 2026-08-12 | Derakhshan Behrad | +50,000 | - | - |
| 2026-08-12 | Derakhshan Behrad | -7,500 | - | - |
| 2026-08-12 | Derakhshan Behrad | -5,781 | - | - |
| 2026-08-12 | Derakhshan Behrad | -2,475 | $43.6984 | $108,154 |
| 2026-08-12 | Derakhshan Behrad | -150 | $44.4433 | $6,666 |
| 2026-08-12 | Derakhshan Behrad | -304 | $44.5018 | $13,529 |
| 2026-08-12 | Derakhshan Behrad | -2,171 | $43.7934 | $95,075 |
| 2026-08-12 | Derakhshan Behrad | +7,500 | - | - |
| 2026-08-12 | Derakhshan Behrad | +5,781 | - | - |
| 2026-08-12 | Nofi Michael | +48,750 | - | - |
| 2026-08-12 | Nofi Michael | +24,375 | - | - |
| 2026-08-12 | Donovan Joanne M. | +65,000 | - | - |
| 2026-08-12 | Donovan Joanne M. | +32,500 | - | - |
| 2026-08-12 | Donovan Joanne M. | -7,031 | - | - |
| 2026-08-12 | Donovan Joanne M. | -5,781 | - | - |
| 2026-08-12 | Donovan Joanne M. | -800 | $44.5175 | $35,614 |
| 2026-08-12 | Donovan Joanne M. | -104 | $44.4253 | $4,620 |
| 2026-08-12 | Donovan Joanne M. | -2,779 | $43.7073 | $121,463 |
| 2026-08-12 | Donovan Joanne M. | -2,839 | $43.784 | $124,303 |
| 2026-08-12 | Donovan Joanne M. | +7,031 | - | - |
| 2026-08-12 | Donovan Joanne M. | +5,781 | - | - |
| 2026-08-12 | MOORE JOHN R | +65,000 | - | - |
| 2026-08-12 | MOORE JOHN R | +32,500 | - | - |
| 2026-08-12 | MOORE JOHN R | -6,718 | - | - |
| 2026-08-12 | MOORE JOHN R | -5,781 | - | - |
| 2026-08-12 | MOORE JOHN R | -2,419 | $43.7985 | $105,949 |
| 2026-08-12 | MOORE JOHN R | -99 | $44.5019 | $4,406 |
| 2026-08-12 | MOORE JOHN R | -59 | $44.4142 | $2,620 |
| 2026-08-12 | MOORE JOHN R | -2,439 | $43.8081 | $106,848 |
| 2026-08-12 | MOORE JOHN R | +6,718 | - | - |
| 2026-08-12 | MOORE JOHN R | +5,781 | - | - |
| 2026-08-12 | KOCH KEVIN | +200,000 | - | - |
| 2026-08-12 | KOCH KEVIN | +100,000 | - | - |
| 2026-08-12 | KOCH KEVIN | -21,875 | - | - |
| 2026-08-12 | KOCH KEVIN | -17,969 | - | - |
| 2026-08-12 | KOCH KEVIN | -913 | $44.33 | $40,473 |
| 2026-08-12 | KOCH KEVIN | -8,276 | $43.6582 | $361,315 |
| 2026-08-12 | KOCH KEVIN | -8,782 | $43.6408 | $383,254 |
| 2026-08-12 | KOCH KEVIN | +21,875 | - | - |
| 2026-08-12 | KOCH KEVIN | +17,969 | - | - |
| 2026-07-01 | Russell Alan J | -69,648 | - | - |
| 2026-07-01 | Russell Alan J | -130,352 | - | - |
| 2026-07-01 | Russell Alan J | -69,648 | $39.4089 | $2,744,751 |
| 2026-07-01 | Russell Alan J | -130,352 | $39.406 | $5,136,651 |
| 2026-07-01 | Russell Alan J | +69,648 | $0.18 | $12,537 |
| 2026-07-01 | Russell Alan J | +130,352 | $0.45 | $58,658 |
| 2026-07-01 | Fox Jonathan C | +319 | - | - |
| 2026-06-05 | ROOT JONATHAN D | +16,377 | - | - |
| 2026-06-05 | Brege Laura | +16,377 | - | - |
| 2026-06-05 | Morris Arlene | +16,377 | - | - |
| 2026-06-05 | Thompson Peter A. | +16,377 | - | - |
| 2026-06-05 | Martin Christopher Nathan | +16,377 | - | - |
| 2026-06-05 | Edris Badreddin | +8,188 | - | - |
| 2026-06-05 | Edris Badreddin | +5,619 | - | - |
| 2026-06-05 | Fox Jonathan C | +16,377 | - | - |
| 2026-05-05 | Donovan Joanne M. | -50,000 | - | - |
| 2026-05-05 | Donovan Joanne M. | -50,000 | $38.568 | $1,928,400 |
| 2026-05-05 | Donovan Joanne M. | +50,000 | $7.08 | $354,000 |
| 2026-05-04 | Donovan Joanne M. | -5,230 | $31.2931 | $163,663 |
| 2026-04-01 | Fox Jonathan C | +339 | - | - |
| 2026-04-01 | Donovan Joanne M. | -28,662 | - | - |
| 2026-04-01 | Donovan Joanne M. | -28,662 | $32.3109 | $926,095 |
| 2026-04-01 | Donovan Joanne M. | +28,662 | $7.08 | $202,927 |
| 2026-03-31 | Donovan Joanne M. | -21,338 | - | - |
| 2026-03-31 | Donovan Joanne M. | -21,338 | $32.1168 | $685,308 |
| 2026-03-31 | Donovan Joanne M. | +21,338 | $7.08 | $151,073 |
| 2026-03-27 | Donovan Joanne M. | -6,735 | $30.9778 | $208,635 |
| 2026-03-27 | Donovan Joanne M. | -9,623 | $30.9778 | $298,099 |
| 2026-01-21 | Edris Badreddin | -13,690 | - | - |
| 2026-01-21 | Edris Badreddin | -17,236 | - | - |
| 2026-01-21 | Edris Badreddin | -7,605 | - | - |
| 2026-01-21 | Edris Badreddin | -66,477 | - | - |
| 2026-01-21 | Edris Badreddin | -10,463 | - | - |
| 2026-01-21 | Edris Badreddin | -66,477 | $29.44 | $1,957,083 |
| 2026-01-21 | Edris Badreddin | -10,463 | $29.44 | $308,031 |
| 2026-01-21 | Edris Badreddin | -7,605 | $29.44 | $223,891 |
| 2026-01-21 | Edris Badreddin | -17,236 | $29.44 | $507,428 |
| 2026-01-21 | Edris Badreddin | -13,690 | $29.44 | $403,034 |
| 2026-01-21 | Edris Badreddin | +7,605 | $0.71 | $5,400 |
| 2026-01-21 | Edris Badreddin | +66,477 | $1.93 | $128,301 |
| 2026-01-21 | Edris Badreddin | +10,463 | $1.93 | $20,194 |
| 2026-01-21 | Edris Badreddin | +17,236 | $0.64 | $11,031 |
| 2026-01-21 | Edris Badreddin | +13,690 | $0.39 | $5,339 |
| 2026-01-02 | Fox Jonathan C | +473 | - | - |
| 2025-11-19 | Martin Christopher Nathan | +45,150 | - | - |
| 2025-11-12 | Russell Alan J | -100,000 | - | - |
| 2025-11-12 | Russell Alan J | -100,000 | $21.1245 | $2,112,450 |
| 2025-11-12 | Russell Alan J | +100,000 | $0.18 | $18,000 |
| 2025-11-11 | Fox Jonathan C | +10,700 | $18.6358 | $199,403 |
| 2025-11-10 | Nofi Michael | +262,500 | - | - |
| 2025-11-10 | Nofi Michael | +43,750 | - | - |